文献速递认知障碍与痴呆

我们能在多早诊断阿尔茨海默病(以及这足够吗)?2017年Wartenberg讲座

How early can we diagnose Alzheimer disease (and is it sufficient)? The 2017 Wartenberg lecture.
PubMed 文献 · Neurology · 2018-08-08

本文回顾阿尔茨海默病(AD)诊断概念的转变:从临床-病理诊断到借助神经影像和脑脊液生物标志物在生前识别AD病理。AD病理仅是衰老认知变化的多病因之一,诊断需整合多重病理要素,单一AD标志物虽提高病因特异性但不足以完整解释认知改变。

要点

  • AD诊断已从临床-病理诊断转向生物标志物支持的生前病理识别。
  • 神经影像和脑脊液标志物可提高临床综合征病因诊断的特异性。
  • AD病理常与其他病理共同贡献于衰老认知变化,诊断解释需综合多重要素。

核心结论

  • AD诊断能力正随生物标志物发展而演变,但AD病理仅是衰老认知变化复杂病因的一部分。

研究设计与样本

  • 2017年Wartenberg讲座,基于文献与概念模型回顾AD诊断框架的演变。

主要发现

  • 过去数十年AD为临床-病理诊断,需尸检发现淀粉样斑块和tau神经原纤维缠结才能确诊。
  • 神经影像和脑脊液等生物标志物可在生前识别AD病理,提高临床综合征病因诊断的精确性。
  • 提出的病理要素与临床症状时间关系的假设模型已极大影响该领域。
  • 衰老认知变化的神经病理常由多重病理实体共同贡献,AD改变仅为其中重要成分。

关键数值与推荐

  • AD的确定性诊断传统上需尸检证实淀粉样斑块和tau神经原纤维缠结。
  • 生前AD病理识别可借助神经影像和脑脊液生物标志物。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A seismic shift in our understanding of the ability to diagnose Alzheimer disease (AD) is occurring. For the last several decades, AD has been a clinical-pathologic diagnosis, and this conceptualization of the disease has served the field well. Typically, the clinician would identify a syndrome such as mild cognitive impairment or dementia, and label the condition as "probable AD" since the diagnosis of definite AD could not be made until an autopsy revealed the presence of amyloid plaques and tau-based neurofibrillary tangles. However, with the advent of biomarkers for AD including neuroimaging and CSF, the identification of AD pathology can be made in life, which greatly enhances the ability of clinicians to be precise about the underlying etiology of a clinical syndrome. Hypothetical models of the temporal relation among the pathologic elements and the clinical symptoms have been proposed and have influenced the field enormously. This has enabled clinicians to be specific about the underlying cause of a given clinical syndrome. As such, the diagnostic capability of the clinician is evolving. However, AD pathology is only a component of the puzzle describing the causes of cognitive changes in aging. Most often, there is a multitude of pathologic entities contributing to the neuropathologic explanation of cognitive changes in aging. AD changes contribute important elements to the diagnosis, but the final answer is more complex. The field of aging and dementia will have to incorporate these additional elements.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Petersen RC. How early can we diagnose Alzheimer disease (and is it sufficient)? The 2017 Wartenberg lecture. Neurology. 2018. PMID: 30089620. doi:10.1212/WNL.0000000000006088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。